as an adjunct to a diet to lower high total cholesterol, LDL-C, apo-B, and triglycerides in adults, adolescents, and children 10 years of age or older with primary hypercholesterolemia, including familial hypercholesterolemia (heterozygous variant) or combined (mixed) hyperlipidemia ( Fredrickson type IIa and IIb, respectively) when response to diet and other non-drug treatments is inadequate
to lower high total cholesterol, LDL-C in adults with homozygous familial hypercholesterolemia, as an adjunct to other lipid-lowering therapies (eg, LDL apheresis) or if such treatments are not available
prevention of cardiovascular events in adult patients with a high risk of developing primary cardiovascular events, as an adjunct to the correction of other risk factors
secondary prevention of cardiovascular complications in patients with coronary artery disease in order to reduce mortality, myocardial infarction, strokes, repeated hospitalizations for angina pectoris and the need for revascularization
Contraindications
There are contraindications, consult with a specialist before use
Thanks! Form Submitted Successfully.
Thanks!
Your data has been sent successfully!
Используя сайт, вы предоставляете согласие на обработку ваших персональных данных с помощью сервисов веб-аналитики. Чтобы ознакомиться с нашими Положениями о конфиденциальности и об использовании
файлов cookie, нажмите здесь.